Blueprint Medicines
BPMC
$105.56
Share price
-0.75%
Change (1 day)
85.88%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - P/B ratio
P/B ratio as of June 2024 : 21.4
According to Blueprint Medicines
's latest financial reports the company has a price-to-book ratio of 21.4.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Blueprint Medicines - P/B ratio (from 2015 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 42.9 | 742.97% |
| 2022-12-31 | 5.09 | -21.55% |
| 2021-12-31 | 6.49 | 52.7% |
| 2020-12-31 | 4.25 | -49.98% |
| 2019-12-31 | 8.50 | 50.03% |
| 2018-12-31 | 5.67 | 7.87% |
| 2017-12-31 | 5.25 | 20.63% |
| 2016-12-31 | 4.35 | -12.06% |
| 2015-12-31 | 4.95 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | 0.8141 | -96.20% | 🇺🇸 USA |
 OPKO Health
OPK | 0.7844 | -96.34% | 🇺🇸 USA |
 Isoray
ISR | 1.95 | -90.93% | 🇺🇸 USA |